Solventum rises after Argus upgrades to 'buy'

Solventum

01/07/2025 16:01

** Medical device maker Solventum's SOLV.N shares rise ~2.6% to $77.82

** Argus Research upgrades Solventum to "buy" from "hold"

** Brokerage says SOLV transformed into  faster-growing and higher-margin business model

** Argus raises SOLV's 2026 adjusted EPS estimate to $5.98 from $5.95

** Four of 13 brokerages rate stock "buy" or higher, eight "hold" and one "sell"; their median PT is $85 - LSEG data

** Including session's moves, stock up ~17.3% YTD

 (Reporting by Prakhar Srivastava in Bengaluru)

 ((Prakhar.srivastava2@thomsonreuters.com))